X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TEVA PHARMA (Israel) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   TEVA PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
TEVA PHARMA
Dec-13
CADILA HEALTHCARE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs5582,924-   
Low Rs3622,540-   
Sales per share (Unadj.) Rs116.31,678.1-  
Earnings per share (Unadj.) Rs17.9104.8-  
Cash flow per share (Unadj.) Rs23.1240.5-  
Dividends per share (Unadj.) Rs3.5091.77-  
Dividend yield (eoy) %0.83.4 22.7%  
Book value per share (Unadj.) Rs85.41,864.0-  
Shares outstanding (eoy) m1,023.74848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.6 242.8%   
Avg P/E ratio x25.726.1 98.7%  
P/CF ratio (eoy) x19.911.4 174.9%  
Price / Book Value ratio x5.41.5 367.2%  
Dividend payout %19.687.5 22.4%   
Avg Mkt Cap Rs m470,6642,316,694 20.3%   
No. of employees `00011.844.9 26.3%   
Total wages/salary Rs m18,5450-   
Avg. sales/employee Rs Th10,072.731,660.8 31.8%   
Avg. wages/employee Rs Th1,569.10-   
Avg. net profit/employee Rs Th1,547.71,977.8 78.3%   
INCOME DATA
Net Sales Rs m119,0491,422,996 8.4%  
Other income Rs m1,1320-   
Total revenues Rs m120,1811,422,996 8.4%   
Gross profit Rs m28,475389,688 7.3%  
Depreciation Rs m5,388115,022 4.7%   
Interest Rs m91127,950 3.3%   
Profit before tax Rs m23,308246,716 9.4%   
Minority Interest Rs m6281,121 56.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-161,956 0.0%   
Tax Rs m5,644-3,012 -187.4%   
Profit after tax Rs m18,29288,893 20.6%  
Gross profit margin %23.927.4 87.3%  
Effective tax rate %24.2-1.2 -1,983.4%   
Net profit margin %15.46.2 246.0%  
BALANCE SHEET DATA
Current assets Rs m82,005961,086 8.5%   
Current liabilities Rs m60,720838,148 7.2%   
Net working cap to sales %17.98.6 207.0%  
Current ratio x1.41.1 117.8%  
Inventory Days Days7391 80.5%  
Debtors Days Days9896 102.5%  
Net fixed assets Rs m83,703464,782 18.0%   
Share capital Rs m1,0243,503 29.2%   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,4451,580,678 5.5%   
Long term debt Rs m25,551727,609 3.5%   
Total assets Rs m180,6533,252,001 5.6%  
Interest coverage x26.69.8 270.5%   
Debt to equity ratio x0.30.5 63.5%  
Sales to assets ratio x0.70.4 150.6%   
Return on assets %10.63.6 295.8%  
Return on equity %20.95.6 372.0%  
Return on capital %22.04.9 445.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,193226,752 4.1%  
From Investments Rs m-9,737-80,347 12.1%  
From Financial Activity Rs m515-272,004 -0.2%  
Net Cashflow Rs m-29-125,600 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 70.05 Rs / USD

Compare CADILA HEALTHCARE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare CADILA HEALTHCARE With: ALEMBIC PHARMA  VENUS REMEDIES  DR. REDDYS LAB  AJANTA PHARMA  DIVIS LABORATORIES  



Today's Market

Indian Share Markets Open Flat; Rupee Hits 70-Mark Again(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.5% while the Hang Seng is flat.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Apr 25, 2019 10:21 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS